-
-
-
-
-
-
-
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
-
-
-
-
-
-
-
Collegium to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Jefferies Downgrades Collegium Pharmaceutical (COLL) to Hold, 'Well-Played Cap Deployment Strategy Yields Windfall for Investors'
-
-
-
-
-
-
-
Jefferies Assumes Collegium Pharmaceutical (COLL) at Buy
-
-
-
-
-
-
-
Collegium Pharma (COLL) Announces $25 Million Accelerated Share Repurchase Program
-
-
-
-
-
-
-
Collegium to Participate in Upcoming Investor Conference
-
-
-
-
-
-
-
Collegium Pharma (COLL) Announces Proposed $125M Convertible Senior Notes Offering
-
73,691 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

